Back

Long-term outcomes after medical therapy, alcohol septal ablation, and myectomy in patients with hypertrophic obstructive cardiomyopathy

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk stratification in hypertrophic cardiomyopathy Cardiomyopathies ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Shanshan Zhai

Fuwai Hospital, CAMS and PUMC, Beijing (China)

4 More presentations in this session

Presentation thumbnail
State of the art in risk stratification in hypertrophic cardiomyopathy.
Doctor P. Spirito (Monza, IT)
Slides Video
Presentation thumbnail
Association of global extracellular volume and late gadolinium enhancement with the estimated 5 year risk of sudden cardiac death according to HCM risk-SCD score in hypertrophic cardiomyopathy
Doctor J. Muench (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy
Doctor A. Giamundo (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Future direction for research in sudden death prediction in hypertrophic cardiomyopathy .
Professor P. Elliott (London, GB)
Slides Video

Access the full session

Session thumbnail
Risk stratification in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources